168 related articles for article (PubMed ID: 11008727)
21. Effects of a concanavalin A-binding biliary glycoprotein on nucleation time of gallbladder bile.
Nakano A; Masuzawa S; Ogura K; Fukazawa S; Nakamoto K; Sekido H; Fukushima T; Tsuchiya S
Gastroenterol Jpn; 1990 Feb; 25(1):88-92. PubMed ID: 2307338
[TBL] [Abstract][Full Text] [Related]
22. [Effect of hypolipidemic treatment on the composition of bile and the risk or cholesterol gallstone disease].
Zák A; Zeman M; Hrubant K; Vecka M; Tvrzická E
Cas Lek Cesk; 2007; 146(1):24-34. PubMed ID: 17310581
[TBL] [Abstract][Full Text] [Related]
23. Bile concentration is a key factor for nucleation of cholesterol crystals and cholesterol saturation index in gallbladder bile of gallstone patients.
van Erpecum KJ; van Berge Henegouwen GP; Stoelwinder B; Schmidt YM; Willekens FL
Hepatology; 1990 Jan; 11(1):1-6. PubMed ID: 2295460
[TBL] [Abstract][Full Text] [Related]
24. Dietary N-3 polyunsaturated fatty acids decrease biliary cholesterol saturation in gallstone disease.
Berr F; Holl J; Jüngst D; Fischer S; Richter WO; Seifferth B; Paumgartner G
Hepatology; 1992 Oct; 16(4):960-7. PubMed ID: 1398503
[TBL] [Abstract][Full Text] [Related]
25. Administration of a terpene mixture inhibits cholesterol nucleation in bile from patients with cholesterol gallstones.
von Bergmann K; Beck A; Engel C; Leiss O
Klin Wochenschr; 1987 May; 65(10):458-62. PubMed ID: 3599793
[TBL] [Abstract][Full Text] [Related]
26. Association between cholesterol-phospholipid vesicles and cholesterol crystals in human gallbladder bile.
Schriever CE; Jüngst D
Hepatology; 1989 Apr; 9(4):541-6. PubMed ID: 2925158
[TBL] [Abstract][Full Text] [Related]
27. Gallbladder emptying in vivo, bile composition, and nucleation of cholesterol crystals in patients with cholesterol gallstones.
Stolk MF; van Erpecum KJ; Renooij W; Portincasa P; van de Heijning BJ; vanBerge-Henegouwen GP
Gastroenterology; 1995 Jun; 108(6):1882-8. PubMed ID: 7768394
[TBL] [Abstract][Full Text] [Related]
28. Biliary lipid output and bile acid kinetics in cholesterol gallstone disease. Evidence for an increased hepatic secretion of cholesterol in Swedish patients.
Nilsell K; Angelin B; Liljeqvist L; Einarsson K
Gastroenterology; 1985 Aug; 89(2):287-93. PubMed ID: 4007420
[TBL] [Abstract][Full Text] [Related]
29. Quantification of cholesterol nucleation promoting activity in human gallbladder bile.
Drapers JA; Groen AK; Stout JP; Noordam C; Hoek FJ; Jansen PL; Tytgat GN
Clin Chim Acta; 1987 Jun; 165(2-3):295-302. PubMed ID: 3652451
[TBL] [Abstract][Full Text] [Related]
30. Effects of pravastatin and ursodeoxycholic acid on cholesterol and bile acid metabolism in patients with cholesterol gallstones.
Okamoto S; Nakano K; Kosahara K; Kishinaka M; Oda H; Ichimiya H; Chijiiwa K; Kuroki S
J Gastroenterol; 1994 Feb; 29(1):47-55. PubMed ID: 8199696
[TBL] [Abstract][Full Text] [Related]
31. Increased biliary protein precedes gallstone formation.
Moser AJ; Abedin MZ; Roslyn JJ
Dig Dis Sci; 1994 Jun; 39(6):1313-20. PubMed ID: 8200266
[TBL] [Abstract][Full Text] [Related]
32. Human gallbladder bile becomes lithogenic during short-term intravenous hyperalimentation.
Nakano K; Chijiiwa K; Noshiro H; Hirota I; Yamasaki T
J Surg Res; 1992 Oct; 53(4):396-401. PubMed ID: 1405620
[TBL] [Abstract][Full Text] [Related]
33. The effects of the 3-hydroxy, 3-methylglutaryl coenzyme A reductase inhibitor pravastatin on bile composition and nucleation of cholesterol crystals in cholesterol gallstone disease.
Smit JW; van Erpecum KJ; Renooij W; Stolk MF; Edgar P; Doornewaard H; Vanberge-Henegouwen GP
Hepatology; 1995 Jun; 21(6):1523-9. PubMed ID: 7768495
[TBL] [Abstract][Full Text] [Related]
34. Nucleation time: a key factor in the pathogenesis of cholesterol gallstone disease.
Holan KR; Holzbach RT; Hermann RE; Cooperman AM; Claffey WJ
Gastroenterology; 1979 Oct; 77(4 Pt 1):611-7. PubMed ID: 467918
[TBL] [Abstract][Full Text] [Related]
35. Biliary lipid output during three meals and an overnight fast. I. Relationship to bile acid pool size and cholesterol saturation of bile in gallstone and control subjects.
Northfield TC; Hofmann AF
Gut; 1975 Jan; 16(1):1-11. PubMed ID: 806491
[TBL] [Abstract][Full Text] [Related]
36. Is duodenal bile representative of gallbladder bile? A comparative study.
Choudhuri G; Agarwal DK; Saraswat VA; Negi TS; Saxena R; Kapoor VK
Scand J Gastroenterol; 1993 Oct; 28(10):920-3. PubMed ID: 8266023
[TBL] [Abstract][Full Text] [Related]
37. Bile acid pools, kinetics and biliary lipid composition before and after cholecystectomy.
Almond HR; Vlahcevic ZR; Bell CC; Gregory DH; Swell L
N Engl J Med; 1973 Dec; 289(23):1213-6. PubMed ID: 4748594
[No Abstract] [Full Text] [Related]
38. Gallbladder motility and cholesterol crystallization in bile from patients with pigment and cholesterol gallstones.
Portincasa P; Di Ciaula A; Vendemiale G; Palmieri V; Moschetta A; Vanberge-Henegouwen GP; Palasciano G
Eur J Clin Invest; 2000 Apr; 30(4):317-24. PubMed ID: 10759880
[TBL] [Abstract][Full Text] [Related]
39. Supersaturated bile from obese patients without gallstones supports cholesterol crystal growth but not nucleation.
Whiting MJ; Watts JMcK
Gastroenterology; 1984 Feb; 86(2):243-8. PubMed ID: 6690352
[TBL] [Abstract][Full Text] [Related]
40. Gallbladder bile composition in patients with Crohn 's disease.
Lapidus A; Akerlund JE; Einarsson C
World J Gastroenterol; 2006 Jan; 12(1):70-4. PubMed ID: 16440420
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
